A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

Non-active site mutations such as L50F are crucial for restoring the viral fitness of SARS-CoV-2 main protease. Here, the authors use full-length Mpro protein as substrate and demonstrate that ...

Scientists from Doherty Institute and Monash University have identified T cells that recognize multiple flu strains, even as ...

In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field: Shelton, Connecticut Thursda ...

Efforts to contain the spread of SARS-CoV-2 may benefit from a new analytical tool developed by a team led by biologists at Boston College, who report their computer simulation of molecular ...

A second subtype of H5 bird flu, known as D1.1, was detected in dairy cattle and infected one worker in the US state of ...

HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary artery lesion-based plaque volume, according to a study ...